BIOMAT Database Logo BIOMAT Database Logo

Antidiuretic action of tachykinin NK-3 receptor in the rat paraventricular nucleus. 1996

T Eguchi, and Y Takano, and T Hatae, and R Saito, and Y Nakayama, and Y Shigeyoshi, and H Okamura, and J E Krause, and H Kamiya
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Fukuoka University, Japan.

Studies were performed on the central antidiuretic actions via the tachykinin NK-3 receptor in the rat hypothalamic paraventricular nucleus (PVN). Microinjections of the selective tachykinin NK-3 receptor agonist senktide (2-200 pmol) into the PVN resulted in prolonged inhibition of urine output in water-loaded rats, its effect being dose-dependent. The antidiuretic action of senktide was blocked by pretreatment with the vasopressin V2 receptor antagonist OPC-31260 (1 mg/kg, i.v.), but not by microinjection of the angiotensin II AT-1 receptor antagonist losartan (1 nmol) into the PVN. NK-3 receptor mRNA was strongly detected in the magnocellular part of the PVN and the supraoptic nucleus (SON) of the hypothalamus as detected by in situ hybridization histochemistry. Moreover, [3H]senktide binding sites were also detected in the PVN and the SON by receptor autoradiography. These findings suggest that NK-3 receptors in the PVN may be involved in water regulation by stimulation of vasopressin secretion from the posterior pituitary gland, and that vasopressin caused water reabsorbtion via the kidney V2 receptor.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D008845 Microinjections The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes. Microinjection
D010286 Paraventricular Hypothalamic Nucleus Nucleus in the anterior part of the HYPOTHALAMUS. Hypothalamic Paraventricular Nucleus,Paraventricular Nucleus,Hypothalamic Nucleus, Paraventricular,Nucleus, Hypothalamic Paraventricular,Nucleus, Paraventricular,Nucleus, Paraventricular Hypothalamic,Paraventricular Nucleus, Hypothalamic
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001713 Biphenyl Compounds Whitish aromatic crystalline organic compounds made up of two conjoined BENZENE rings. Compounds, Biphenyl
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013373 Substance P An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses. Euler-Gaddum Substance P,Hypothalamic Substance P,SP(1-11),Euler Gaddum Substance P,Substance P, Euler-Gaddum,Substance P, Hypothalamic

Related Publications

T Eguchi, and Y Takano, and T Hatae, and R Saito, and Y Nakayama, and Y Shigeyoshi, and H Okamura, and J E Krause, and H Kamiya
Central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the rat hypothalamus.
November 1992, Brain research,
T Eguchi, and Y Takano, and T Hatae, and R Saito, and Y Nakayama, and Y Shigeyoshi, and H Okamura, and J E Krause, and H Kamiya
The mechanism of central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the hypothalamus in rats.
July 1993, Regulatory peptides,
T Eguchi, and Y Takano, and T Hatae, and R Saito, and Y Nakayama, and Y Shigeyoshi, and H Okamura, and J E Krause, and H Kamiya
Tachykinin NK(3)receptor involvement in anxiety.
April 1999, Neuropeptides,
T Eguchi, and Y Takano, and T Hatae, and R Saito, and Y Nakayama, and Y Shigeyoshi, and H Okamura, and J E Krause, and H Kamiya
Tachykinin receptor (NK(1), NK(2), NK(3)) binding sites in the rat caudal brainstem following neonatal capsaicin administration.
July 2003, Brain research,
T Eguchi, and Y Takano, and T Hatae, and R Saito, and Y Nakayama, and Y Shigeyoshi, and H Okamura, and J E Krause, and H Kamiya
Trafficking of tachykinin neurokinin 3 receptor to nuclei of neurons in the paraventricular nucleus of the hypothalamus following osmotic challenge.
July 2008, Neuroscience,
T Eguchi, and Y Takano, and T Hatae, and R Saito, and Y Nakayama, and Y Shigeyoshi, and H Okamura, and J E Krause, and H Kamiya
Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats.
September 1993, Neuroscience letters,
T Eguchi, and Y Takano, and T Hatae, and R Saito, and Y Nakayama, and Y Shigeyoshi, and H Okamura, and J E Krause, and H Kamiya
Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor.
February 2001, European journal of pharmacology,
T Eguchi, and Y Takano, and T Hatae, and R Saito, and Y Nakayama, and Y Shigeyoshi, and H Okamura, and J E Krause, and H Kamiya
Mechanism of action for reduction of ethanol intake in rats by the tachykinin NK-3 receptor agonist aminosenktide.
December 1998, Pharmacology, biochemistry, and behavior,
T Eguchi, and Y Takano, and T Hatae, and R Saito, and Y Nakayama, and Y Shigeyoshi, and H Okamura, and J E Krause, and H Kamiya
SR142801 behaves as a tachykinin NK-3 receptor agonist on a spinal nociceptive reflex in the rat.
January 2000, Life sciences,
T Eguchi, and Y Takano, and T Hatae, and R Saito, and Y Nakayama, and Y Shigeyoshi, and H Okamura, and J E Krause, and H Kamiya
SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
August 2002, European journal of pharmacology,
Copied contents to your clipboard!